As of 2024-12-14, the Fair Value of Surface Oncology Inc (SURF) is -7.60 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.07 USD, the upside of Surface Oncology Inc is -810.68%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -6.60 | -54.80 | 59.30 | -78.48 | -63.59 | -28.83 |
| YoY growth | 85.46% | -730.30% | 208.21% | -232.35% | 18.98% | -130.00% |
| Market Cap (mil) | 65.08 |
| P/E | |
| Forward P/E | -0.70x |
| EPS | -1.52 |
| Avg earnings growth rate | -130.00% |
| TTM earnings | -92.50 |